Search | Page 4 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

    ... is a single arm pilot study for patients using α/β T cell -depleted PSCT in with alternative donor sources with hematologic ... leukemia Disease status: chronic phase, accelerated phase or blast crisis now in second chronic phase. Mixed lineage or biphenotypic ...

    Clinical Trial last updated 06/06/2016 - 3:10pm.

  2. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

    ... is a single arm pilot study for patients using α/β T cell -depleted PSCT in with alternative donor sources with hematologic ... leukemia Disease status: chronic phase, accelerated phase or blast crisis now in second chronic phase. Mixed lineage or biphenotypic ...

    Clinical Trial last updated 06/03/2016 - 2:45pm.

  3. A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

    ... eligible for, or opted not to participate in allogenic stem cell transplantation h. Off all other treatments for MDS (including AZA ... diagnosed with AML (defined as a bone marrow blast percentage of >30%) d.         Suitable candidate to receive ...

    Clinical Trial last updated 11/29/2016 - 8:29am.

  4. Growth Factors

    ... Red Cell Growth Factor Red cell growth ... white cell growth factors can increase the growth of blast cells in patients with high-risk MDS. This can be a serious problem. For ...

    Topic section last updated 04/06/2016 - 12:37pm.

  5. San Diego Family Takes Action for Awareness

    ... remained in high-risk status he wasn’t qualified, as his blast count had actually increased. We thought things over for a month or two, ... he no longer needed transfusions. A search for a stem cell donor had been started prior to this treatment. Because David is ...

    Patient Chronicle last updated 10/26/2016 - 11:42am.

  6. Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

    ... RATIONALE: A peripheral stem cell transplant may be able to replace blood-forming cells that were ... leukemia Chronic myelogenous leukemia all types except blast crisis (note treated blast crisis in chronic phase is eligible). ...

    Clinical Trial last updated 05/02/2016 - 2:20pm.

  7. Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

    ... help the immune system recover faster following a stem cell transplant . Blood stem cells are very young blood cells that ... second chronic phase, or in CR after accelerated phase or blast crisis. Non-Hodgkins lymphoma with chemo responsive disease in any of ...

    Clinical Trial last updated 04/29/2016 - 1:11pm.

  8. Preventing Stem Cell Transplant Complications With a Blood Separator Machine

    ... Background: - Researchers are working to make stem cell transplant procedures safer and more effective. One complication of ... inhibitors OR Subjects ages 10-80 in accelerated phase or blast transformation. OR 5.1.2.2 Acute lymphoblastic leukemia (ALL): any of ...

    Clinical Trial last updated 05/23/2016 - 10:57am.

  9. Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation

    ... HLA -identical sibling donor peripheral blood stem cell (PBSC) transplantation for the treatment of a high risk malignancy. Up to ... of ≥15%. Chronic myelogenous leukemia all types except blast crisis (note treated blast crisis in chronic phase is eligible) ...

    Clinical Trial last updated 04/29/2016 - 1:48pm.

  10. Intra-Osseous Co-Transplant of UCB and hMSC

    ... donor umbilical cord blood and mesenchymal stromal cell co-transplant in treating patients with hematologic malignancies. Giving ... leukemia (CML) in second chronic phase after accelerated or blast crisis; blast crisis defined as: Blast count ≥ 20% in the ...

    Clinical Trial last updated 05/02/2016 - 11:15am.